Immune-Onc to partner with University of Texas on novel cancer immunotherapy

This article was originally published here

Immune-Onc Therapeutics has signed an exclusive license and collaboration agreement with The University of Texas Health Science Center at Houston (“UTHealth”) and The University of Texas Southwestern Medical Center (“UTSW”), two member institutions of The University of Texas System (“UT System”).

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply